Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial programme

被引：0
|
作者：
Eichenfield, L. F. [1 ,2 ]
Flohr, C. [3 ]
Bangert, C. [4 ]
Irvine, A. D. [5 ]
Weidinger, S. [6 ]
Nesnas, J. [7 ]
Koppensteiner, H. [8 ]
Zhang, F. [9 ]
Rojo, R. [9 ]
Chan, G. [9 ]
机构：
[1] Univ Calif San Diego, San Diego, CA USA
[2] Radys Childrens Hosp San Diego, San Diego, CA USA
[3] Kings Coll London, Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Unit Populat Based Dermatol Res, London, England
[4] Med Univ Vienna, Vienna, Austria
[5] Univ Dublin, Trinity Coll Dublin, St James Hosp, Dublin, Ireland
[6] Univ Hosp Schleswig Holstein, Kiel, Germany
[7] Pfizer Ltd, Surrey, England
[8] Pfizer Inc, Vienna, Austria
[9] Pfizer Inc, Groton, CT 06340 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
525
引用
收藏
页码：E142 / E143
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of abrocitinib in adolescents with moderate-to-severe atopic dermatitis from the JADE clinical trial program
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Bangert, Christine
    Irvine, Alan D.
    Weidinger, Stephan
    Nesnas, John
    Koppensteiner, Herwig
    Zhang, Fan
    Rojo, Ricardo
    Chan, Gary
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis The JADE TEEN Randomized Clinical Trial
    Eichenfield, Lawrence F.
    Flohr, Carsten
    Sidbury, Robert
    Siegfried, Elaine
    Szalai, Zsuzsanna
    Galus, Ryszard
    Yao, Zhirong
    Takahashi, Hidetoshi
    Barbarot, Sebastien
    Feeney, Claire
    Zhang, Fan
    DiBonaventura, Marco
    Rojo, Ricardo
    Valdez, Hernan
    Chan, Gary
    [J]. JAMA DERMATOLOGY, 2021, 157 (10) : 1165 - 1173
  • [3] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    [J]. JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
  • [4] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
  • [5] Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
    Li, Ling
    Yu, Jiajun
    Chen, Baoqing
    Guo, Ying
    Yang, Yufeng
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Efficacy and safety of abrocitinib in combination with topical therapy in adolescents with moderate-to-severe atopic dermatitis: the JADE TEEN randomized clinical trial (vol 157, pg 1165, 2021)
    Zouboulis, C. C.
    Tzellos, T.
    Kyrgidis, A.
    [J]. JAMA DERMATOLOGY, 2021, 157 (10) : 1246 - 1246
  • [7] Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
    Shi, Vivian Y.
    Bhutani, Tina
    Fonacier, Luz
    Deleuran, Mette
    Shumack, Stephen
    Valdez, Hernan
    Zhang, Fan
    Chan, Gary L.
    Cameron, Michael C.
    Yin, Natalie C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 351 - 358
  • [8] Efficacy and safety of abrocitinib in combination with topical therapy in adolescents from China with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE TEEN phase 3 trial
    Yao, Zhirong
    Xu, Aie
    He, Li
    Ding, Yangfeng
    Hu, Guohong
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II23 - II24
  • [9] Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies
    Schmid-Grendelmeier, Peter
    Gooderham, Melinda J.
    Hartmann, Karin
    Konstantinou, George N.
    Fellmann, Marc
    Koulias, Christopher
    Clibborn, Claire
    Biswas, Pinaki
    Brunner, Patrick M.
    [J]. ALLERGY, 2024, 79 (01) : 174 - 183
  • [10] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    [J]. CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1991 - 1992
12345